May 8, 2020
Health Minister Katsunobu Kato Japan’s health ministry approved Gilead Sciences’ antiviral remdesivir on May 7 for the treatment of severely ill patients with COVID-19, making it the first drug to be cleared in the country to treat the disease caused...read more